-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
-
Summary
-
CASI Pharmaceuticals, Inc (DE) annual/quarterly Net Cash Provided by (Used in) Operating Activities history and growth rate from 2010 to 2022.
- CASI Pharmaceuticals, Inc (DE) Net Cash Provided by (Used in) Operating Activities for the quarter ending March 31, 2022 was -$4.24M, a 47% increase year-over-year.
- CASI Pharmaceuticals, Inc (DE) annual Net Cash Provided by (Used in) Operating Activities for 2022 was -$21.1M, a 21.4% increase from 2021.
- CASI Pharmaceuticals, Inc (DE) annual Net Cash Provided by (Used in) Operating Activities for 2021 was -$26.8M, a 3.69% decline from 2020.
- CASI Pharmaceuticals, Inc (DE) annual Net Cash Provided by (Used in) Operating Activities for 2020 was -$25.9M, a 11.4% decline from 2019.
Net Cash Provided by (Used in) Operating Activities, Annual (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Annual Growth (%)